Department of Pediatrics, Division of Child and Adolescent Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Department of Pediatrics, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Mol Genet Genomic Med. 2021 Jul;9(7):e1706. doi: 10.1002/mgg3.1706. Epub 2021 May 27.
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a genetic neurodegenerative condition previously thought to be inherited only in an autosomal recessive pattern through biallelic pathogenic variants in C19orf12. Recent evidence has proposed that MPAN can also follow autosomal dominant forms of inheritance. We present a case of a de novo pathogenic variant in C19orf12 identified in a female with clinical features consistent with a diagnosis of MPAN, adding further evidence that the disease can be inherited in an autosomal dominant fashion.
A 17-year-old Hispanic female was born to non-consanguineous healthy parents. She developed progressive muscle weakness and dystonia beginning when she was 12 years old. Trio, whole-exome sequencing with mitochondrial genome sequencing, and deletion/duplication analysis of both nuclear and mitochondrial genomes was performed in December 2019.
Whole-exome sequencing analysis revealed a single de novo variant in C19orf12. The specific variant is c.256C>T (p.Q86X) located in exon 3.
Our clinical report provides further clinical evidence that MPAN can be inherited in an autosomal dominant or recessive fashion. The patient's age of onset and clinical symptoms are very similar to the previous patient published with this specific variant as well as others with heterozygous pathogenic variants in C19orf12 in Gregory et al. 2019. Our case report highlights the importance of considering both autosomal dominant and autosomal recessive version of MPAN with all patients demonstrating clinical features suggestive of MPAN.
线粒体膜蛋白相关神经退行性变(MPAN)是一种遗传性神经退行性疾病,先前认为仅通过 C19orf12 中的双等位致病性变异以常染色体隐性模式遗传。最近的证据表明,MPAN 也可以遵循常染色体显性遗传形式。我们报告了一例 C19orf12 中的新生致病性变异,该变异发生在一名具有与 MPAN 诊断一致的临床特征的女性中,这进一步证明该疾病可以以常染色体显性方式遗传。
一名 17 岁的西班牙裔女性,出生于非近亲健康父母。她在 12 岁时开始出现进行性肌肉无力和肌张力障碍。2019 年 12 月进行了三人体外显子组测序,伴有线粒体基因组测序,以及核基因组和线粒体基因组的缺失/重复分析。
外显子组测序分析显示 C19orf12 中存在单一新生变异。具体变异为 c.256C>T(p.Q86X),位于外显子 3 中。
我们的临床报告提供了进一步的临床证据,表明 MPAN 可以以常染色体显性或隐性方式遗传。患者的发病年龄和临床症状与之前发表的具有该特定变异的患者以及 Gregory 等人报道的具有 C19orf12 杂合致病性变异的其他患者非常相似。我们的病例报告强调了考虑所有具有提示 MPAN 临床特征的患者的常染色体显性和常染色体隐性 MPAN 的重要性。